Showing 1 - 10 results of 10 for search 'M.V. Sura', query time: 0.02s Refine Results
  1. 1
    PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS

    PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS by M. V. Sura

    Published 2016-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION

    RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION by M. V. Sura

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS?

    NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS? by V.V. Omel'yanovskii, M.V. Sura, N.D. Sveshnikova

    Published 2011-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION

    ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION by M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva

    Published 2015-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS

    ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS by M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva

    Published 2015-05-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017

    Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Ins... by O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov

    Published 2019-11-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES

    REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES by K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva

    Published 2016-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available

    Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available by F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev

    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871

    Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 by V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations

    Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered... by M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov

    Published 2018-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: